Epstein-Barr Virus Infection

12 clinical trials · Condition

Record	Firm	Date
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults (NCT04645147)	National Institute of Allergy and Infectious Diseases (NIAID)	2022-03-29
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults (NCT05164094)	ModernaTX, Inc.	2021-12-28
Mental Training for CFS Following EBV Infection in Adolescents (NCT02499302)	University Hospital, Akershus	2015-10-01
Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA (NCT02135042)	NRG Oncology	2014-04-21
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas (NCT01805037)	Northwestern University	2013-03-05
Administration of Donor T Cells With the Caspase-9 Suicide Gene (NCT01494103)	Baylor College of Medicine	2011-11-01
Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus (NCT00005924)	National Institute of Allergy and Infectious Diseases (NIAID)	2000-06-23
TETRAVI Expanded Access Program (NCT07104591)	Baylor College of Medicine

Every clearance here is in the API, with alerts when new ones post.